Genetic mutations could help guide use of pancreatic cancer drugs; New insights on neuropathic pain, esophageal cancer;

> Johns Hopkins Kimmel Cancer Center scientists say they found at least one-third of the patients' pancreatic cancer tumors have genetic mutations that may someday help guide precision therapy of their disease. Release

> A research group at Hiroshima University has demonstrated that the downregulation of spinal astrocyte connexin43 (Cx43) expression causes sustained neuropathic pain following peripheral nerve injury. Release

> U.K. scientists have found that "jumping genes" may add to the genetic chaos behind more than three-quarters of esophageal cancer cases. Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.